BEAM Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Beam Therapeutics Inc

Watchlist Manager

Watchlist

Price: 35.32 USD 1.52% Market Closed

Market Cap: $3.6B

	Beam Therapeutics Inc NASDAQ:BEAM	US
E	eBay Inc XHAM:EBA	US
W	Wilmar International Ltd XMUN:RTHA	SG
	Indoritel Makmur Internasional Tbk PT IDX:DNET	ID
O	ON Semiconductor Corp XMUN:XS4	US
M	Mitsubishi Estate Co Ltd XMUN:MES	JP
B	Bilfinger SE DUS:GBF	DE

Profitability Summary

Beam Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-227%

Negative 3Y Average Operating Margin

-381%

Operating Margin is Increasing

-476% > -227%

Negative Net Margin

-40%

Negative 3Y Average Net Margin

-304%

Net Margin is Increasing

-408% > -40%

Negative Free Cash Flow Margin

-234%

Negative 3Y Average Free Cash Flow Margin

-332%

Free Cash Flow Margin is Increasing

-475% > -234%

Negative ROE

-6%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-134%

Declining ROIC

-147% > -150%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.